Experimental Autoimmune Encephalomyelitis: In Vivo Induction of Regulatory T Cells Via CTLA-4 Signaling Peptide to Control Autoimmune Encephalomyelitis and Prevent Disease Relapse (Adv. Sci. 14/2021)
Advanced Science(2021)
Abstract
In article number 2004973, Je-Min Choi and co-workers develop a synthetic peptide dNP2-ctCTLA-4 that regulates experimental autoimmune encephalomyelitis progression and relapse in the longterm by inducing Foxp3+ Treg cells in vivo. This peptide induces Treg cells in human peripheral blood mononuclear cells from multiple sclerosis (MS) patients and in a humanized mouse model, demonstrating that it would be a novel therapeutic agent for MS.
MoreTranslated text
Key words
control autoimmune encephalomyelitis,prevent disease relapse,regulatory cells
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined